Smart for Life (SMFL) Competitors

$4.36
-0.32 (-6.84%)
(As of 04/24/2024 ET)

SMFL vs. AKAN, APVO, AMPE, ATHX, CALA, MOTS, BTTX, ACORQ, PTEIQ, and SINT

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Akanda (AKAN), Aptevo Therapeutics (APVO), Ampio Pharmaceuticals (AMPE), Athersys (ATHX), Calithera Biosciences (CALA), Motus GI (MOTS), Better Therapeutics (BTTX), Acorda Therapeutics (ACORQ), PolarityTE (PTEIQ), and Sintx Technologies (SINT). These companies are all part of the "medical" sector.

Smart for Life vs.

Akanda (NASDAQ:AKAN) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership, dividends and community ranking.

Akanda has a net margin of 0.00% compared to Akanda's net margin of -188.32%.

Company Net Margins Return on Equity Return on Assets
AkandaN/A N/A N/A
Smart for Life -188.32%N/A -75.82%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Akanda
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Akanda has higher earnings, but lower revenue than Smart for Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akanda$2.62M0.30-$11.66MN/AN/A
Smart for Life$17.77M0.03-$29.98M-$1.12 thousand0.00

Smart for Life received 1 more outperform votes than Akanda when rated by MarketBeat users.

CompanyUnderperformOutperform
AkandaN/AN/A
Smart for LifeOutperform Votes
1
100.00%
Underperform Votes
No Votes

1.0% of Akanda shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 20.4% of Akanda shares are owned by insiders. Comparatively, 31.7% of Smart for Life shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Akanda has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

In the previous week, Smart for Life had 15 more articles in the media than Akanda. MarketBeat recorded 15 mentions for Smart for Life and 0 mentions for Akanda. Akanda's average media sentiment score of 0.24 beat Smart for Life's score of 0.00 indicating that Smart for Life is being referred to more favorably in the news media.

Company Overall Sentiment
Akanda Neutral
Smart for Life Neutral

Summary

Smart for Life beats Akanda on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$530,000.00$1.28B$4.90B$7.50B
Dividend YieldN/A2.40%2.96%3.94%
P/E Ratio0.003.56163.2015.13
Price / Sales0.0310.652,383.7182.96
Price / CashN/A172.2546.7735.26
Price / Book-0.021.944.624.28
Net Income-$29.98M-$164.88M$103.05M$213.92M
7 Day Performance34.67%0.79%0.32%1.62%
1 Month Performance-27.57%-0.95%-5.22%-3.59%
1 Year Performance-98.55%12.91%9.08%8.17%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AKAN
Akanda
0 of 5 stars
$0.10
-8.9%
N/A-91.8%$902,000.00$2.62M0.0046Gap Down
High Trading Volume
APVO
Aptevo Therapeutics
0.3267 of 5 stars
$0.77
-2.5%
N/A-99.1%$329,000.00$3.11M0.0040Analyst Revision
High Trading Volume
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.30
flat
N/A-93.0%$342,000.00N/A-0.036Gap Down
ATHX
Athersys
0 of 5 stars
$0.00
flat
N/A-99.5%$272,000.00$146,000.000.0024News Coverage
Gap Down
CALA
Calithera Biosciences
0 of 5 stars
$0.05
flat
N/A-27.5%$244,000.00$9.75M0.008Analyst Report
Gap Up
MOTS
Motus GI
1.8071 of 5 stars
$0.08
-51.9%
$28.88
+34,480.8%
-99.4%$420,000.00$320,000.000.0015Gap Down
BTTX
Better Therapeutics
1.5218 of 5 stars
$0.01
flat
$6.00
+64,277.7%
-99.4%$465,000.00N/A-0.0154Gap Down
ACORQ
Acorda Therapeutics
0 of 5 stars
$0.38
-5.0%
N/AN/A$471,000.00$117.63M0.00102Gap Down
PTEIQ
PolarityTE
0 of 5 stars
$0.02
flat
N/AN/A$149,000.00$810,000.00-0.0142Gap Up
SINT
Sintx Technologies
0 of 5 stars
$0.02
flat
N/A-97.6%$519,000.00$1.23M-0.0141Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:SMFL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners